Literature DB >> 14632745

Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA.

L Tasker1, S Marshall-Clarke.   

Abstract

Human neonates are immunologically immature and consequently are highly susceptible to infection. The cellular basis for the dysfunctional immune responses of neonates is not clear, but is likely to reflect the immaturity of both B and T cell populations. Here we have examined the ability of human cord blood B cells to respond to antigen receptor cross-linking and also to CpG containing oligodeoxynucleotides (ODN), and compared their responses with those of adult peripheral blood B cells. Antigen receptor cross-linking with soluble F(ab')2 anti-IgM antibodies, induced HLA-DR and CD86 up-regulation and proliferation to a similar extent in adult and cord blood B cells. Both interleukin (IL)-2 and IL-4 co-stimulated anti-IgM-induced proliferation, but cord blood B cells were less sensitive than adult B cells to the co-stimulatory effects of IL-2. Antigen receptor cross-linking induced secretion of the chemokines macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta in adult and cord blood B cells, and secretion was enhanced by IL-2 or IL-4. CpG-ODN induced up-regulation of HLA-DR and CD86 expression and proliferation of adult and cord blood B cells, and anti-IgM and CPG-ODN synergized in the induction of proliferation. CpG-ODN also induced MIP-1 alpha and MIP-1 alpha secretion in adult and cord blood B cells. In addition to functional studies we examined the expression of CD62L (l-selectin), CCR7 and CXCR5. Our data show that surface expression of CD62L and CCR7 is lower on cord blood B cells than on adult B cells, suggesting that human cord blood B cells may exhibit homing defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632745      PMCID: PMC1808896          DOI: 10.1111/j.1365-2249.2003.02318.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Neonatal immunity: how well has it grown up?

Authors:  S Marshall-Clarke; D Reen; L Tasker; J Hassan
Journal:  Immunol Today       Date:  2000-01

Review 2.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Maintenance of serological memory by polyclonal activation of human memory B cells.

Authors:  Nadia L Bernasconi; Elisabetta Traggiai; Antonio Lanzavecchia
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

4.  CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells.

Authors:  A Zandvoort; M E Lodewijk; N K de Boer; P M Dammers; F G Kroese; W Timens
Journal:  Tissue Antigens       Date:  2001-10

Review 5.  Neonatal and early life vaccinology.

Authors:  C A Siegrist
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

6.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

7.  Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes.

Authors:  A W Griffioen; S W Franklin; B J Zegers; G T Rijkers
Journal:  Clin Immunol Immunopathol       Date:  1993-10

8.  Serum complement profiles in infants and children.

Authors:  M E Norman; E P Gall; A Taylor; L Laster; U R Nilsson
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

9.  Serum complement levels in infancy: age related changes.

Authors:  C A Davis; E H Vallota; J Forristal
Journal:  Pediatr Res       Date:  1979-09       Impact factor: 3.756

10.  B cells and professional APCs recruit regulatory T cells via CCL4.

Authors:  R S Bystry; V Aluvihare; K A Welch; M Kallikourdis; A G Betz
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

View more
  18 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.

Authors:  Cuixia Tian; Grace K Kron; Kevin M Dischert; James N Higginbotham; James E Crowe
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

3.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

4.  Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.

Authors:  John M Davis; Cynthia S Crowson; Keith L Knutson; Sara J Achenbach; Michael A Strausbauch; Terry M Therneau; Eric L Matteson; Sherine E Gabriel; Peter J Wettstein
Journal:  Clin Immunol       Date:  2020-01-08       Impact factor: 3.969

5.  Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells.

Authors:  Matthew A Pettengill; Simon D van Haren; Ning Li; David J Dowling; Ilana Bergelson; Jop Jans; Gerben Ferwerda; Ofer Levy
Journal:  Innate Immun       Date:  2016-06-01       Impact factor: 2.680

6.  An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates.

Authors:  Beth C Holbrook; S Tyler Aycock; Emily Machiele; Elene Clemens; Danielle Gries; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Immunology       Date:  2017-10-24       Impact factor: 7.397

7.  Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naïve Subjects.

Authors:  Karen Liao; Stacy Derbyshire; Kai-Fen Wang; Cherilyn Caucci; Shuo Tang; Claire Holland; Amy Loercher; George R Gunn
Journal:  AAPS J       Date:  2018-03-16       Impact factor: 4.009

Review 8.  Chronic graft-versus-host disease (GVHD) in children.

Authors:  Kristin Baird; Kenneth Cooke; Kirk R Schultz
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

9.  Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques.

Authors:  Citra N Z Mattar; Amit C Nathwani; Simon N Waddington; Niraja Dighe; Christine Kaeppel; Ali Nowrouzi; Jenny Mcintosh; Nuryanti B Johana; Bryan Ogden; Nicholas M Fisk; Andrew M Davidoff; Anna David; Donald Peebles; Marcus B Valentine; Jens-Uwe Appelt; Christof von Kalle; Manfred Schmidt; Arijit Biswas; Mahesh Choolani; Jerry K Y Chan
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

10.  CpG-induced Th1-type response in the downmodulation of early development of allergy and inhibition of B7 expression on T cells of newborn mice.

Authors:  Cyro A de Brito; Ana E Fusaro; Jefferson R Victor; Paula O Rigato; Adriana L Goldoni; Bruno P Muniz; Alberto J S Duarte; Maria N Sato
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.